Chelsea Strategy Group

Regulations affiliated with Bill C- 45 regarding the legalization of cannabis. Formerly known as Bill C-45: An Act Respecting Cannabis and to amend the Controlled Drugs and Substances Act, the Criminal Code and other Acts. Governmental policy towards medical cannabis research, product quality standards, medical cost coverage, and displacement of harder and more addictive drugs Formerly known as Bill C-45: An Act Respecting Cannabis and to amend the Controlled Drugs and Substances Act, the Criminal Code and other Acts. Cannabis Act SC 2018 S16 Cannabis Act; phased implementation of the Act and its impact on medical patients; development of regulations for the industry and the resulting tax implications of these regulations. Canada's policy regarding the rules governing the legalization of marijuana

Seek opportunities for mutual recognition and regulatory alignment with like-minded jurisdictions including via the Canada-US Regulatory Cooperation Council Increase awareness with officials regarding Haleon, its products, manufacturing facilities and contribution to Canada, and discuss ways to build a more competitive operating landscape that encourages manufacturing and research Engage officials on sustainability, plastics and packaging issues Engage officials on international and cross-border trade issues Encourage the development of initiatives and resources to improve health education and inclusivity Communicating the need for a coordinated national approach to scheduling to allow consumers consistent access to health products across the provinces and territories. Advocate for the removal of unnecessary barriers to health product regulations and encourage the development of a detailed plan to implement a modernized National Self Care Framework

Tobacco and Vaping Products Act with regards to the classification of tobacco and vaping products, product regulation, packaging and labeling Schedule 1 of the Excise Act 2001 (Sections 42, 43.1 and 58.2, subsections 216(2) and (3), and section 240) under the Rate of Duty on Tobacco Products Excise Act, 2001 -with regard to tobacco and vaping duties, stamps or collection. Customs Act/Customs Tariff - with regard to customs duties on tobacco and vaping products. Any new legislative or regulatory proposals, or policies, relating to harm reduction as it pertains to combustible tobacco products. Any new legislative or regulatory proposals, or policies, relating to non-combustible, smoke-free, nicotine products Any new legislative or regulatory proposals or policies relating to tobacco and/or vaping including taxation, product regulation, flavouring, packaging and labeling requirements and contraband. Any new legislative or regulatory proposals or policies Legislative Proposal, Bill or Resolution, relating to the recycling of tobacco-related and vaping products.

Amend the cannabis regulatory framework to permit cannabis licensed producers to more effectively communicate on the attributes of cannabis products with consumers. Elimination of the Health Canada annual 2.3% regulatory fee. Amend the cannabis excise duty framework to eliminate the requirement that cannabis producers affix provincial / territory designated excise duty stamps to each individual package of cannabis, to be replaced by either a national excise duty stamp or a digital excise duty stamp. Amend the Excise Duty Framework for on Cannabis products to remove the $1.00 per gram duty with a 10% ad valorem rate. Development of a framework to ensure consistent approach to the measurement and labeling of potency of cannabis products Seek amendments to the regulations and policies that govern the importation and exportation of medical cannabis.

Communicating with officials the economic contribution of the industry to Canada. Communicating on beverage alcohol drinking guidance and labelling. Advocating for amendments to the excise duty framework, specifically with respect to the automatic annual escalator on the federal excise duty for beverage alcohol products.